Clinical trials · Michigan
Vascular Diseases clinical trials in Michigan
We’re tracking 12 recruiting vascular diseases studies with a site in Michigan — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in Michigan
- NCT03683186Enrolling by invitationPhase 3
Long-term study of ralinepag for pulmonary hypertension
This study follows people with pulmonary arterial hypertension (PAH) to see how safe and effective ralinepag is over the long term. It may help your care team understand what to expect from continued treatment and monitoring.
Grand Rapids, MichiganAges 18 years+ - NCT06907147Recruiting
Renal denervation for uncontrolled high blood pressure
This trial tests a procedure called renal denervation to lower blood pressure in people whose medication isn't enough. It uses a special catheter to calm nerves near the kidneys that may be overactive.
Southfield, MichiganAges 18–80 - NCT06297291Recruiting
Long-term safety study for a kidney nerve treatment
This study tests a device that uses ultrasound to calm overactive kidney nerves, which may help lower blood pressure. It is for people with high blood pressure that is hard to control with medication.
Detroit, MichiganAges 18 years+ - NCT07231757Recruiting
Blood pressure study for older adults
This study tests a treatment to lower blood pressure in adults aged 65 and older whose blood pressure is not well controlled with their current medications. It may be an option for those looking for additional ways to manage their hypertension.
Detroit, MichiganAges 65 years+ - NCT07214376Recruiting
Nerve ablation for pulmonary hypertension from left heart disease
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
Detroit, MichiganAges 18–85 - NCT06927739RecruitingPhase 2
Orticumab for heart artery inflammation after a heart attack
This trial tests a drug called orticumab to see if it can reduce inflammation in the arteries of the heart after a heart attack. It may help prevent future heart problems.
Midland, MichiganAges 18 years+ - NCT04774159RecruitingPhase 3
Low-dose colchicine to lower risk in leg artery disease
This trial tests whether low-dose colchicine can reduce “residual” risk—future heart and blood-vessel problems—in people with peripheral artery disease (PAD). It targets PAD symptoms and complications like poor blood flow in the legs, even after certain procedures.
Detroit, MichiganAges 18 years+ - NCT06087029Recruiting
Improving outcomes in aortic dissection
This study tests a minimally invasive procedure called TEVAR to repair a type B aortic dissection (a tear in the wall of the main artery from your heart). It may help prevent further damage and improve recovery.
Ann Arbor, MichiganAges 21 years+ - NCT06535854Recruiting
Prevail Stent Study for Heart Disease
This study tests a new type of stent for people with narrowed heart arteries causing chest pain or a recent mild heart attack. It aims to see if the stent is safe and effective in improving blood flow without serious side effects.
Ann Arbor, MichiganAges 18 years+ - NCT07076082RecruitingPhase 4
Vascular trial registry for leg artery procedures
This study is a registry that collects information on people who have or will have a leg artery procedure to open blocked blood vessels. It helps doctors learn more about how well these procedures work and how to improve care.
Detroit, MichiganAges 45 years+ - NCT06687590Recruiting
Serranator POINT FORCE registry for leg and dialysis access
This registry study is following patients whose blocked leg or dialysis access arteries are treated with a special balloon (Serranator) that helps open the vessel. The goal is to see how well the device works in real-world use.
Detroit, MichiganAges 18 years+ - NCT01524276Recruiting
Registry to track outcomes of Medtronic medical devices
This is a follow-up registry that collects information from people who have (or will receive) an eligible Medtronic device. It helps the company and doctors better understand how the device works in real-world use.
Ann Arbor, MichiganAges Any age
Vascular Diseases trials by city in Michigan
Where these studies are running in Michigan
Institutions with a site for the recruiting vascular diseases studies listed above.
- Henry Ford Health · 7 studies
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital · 4 studies
- University of Michigan · 2 studies
- Abcentra Investigational Site
- Henry Ford Providence Southfield Hospital
- Trinity Health Ann Arbor Hospital
What taking part in a vascular diseases study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Vascular Diseases trials in other states
Common questions
- Are there vascular diseases clinical trials in Michigan?
- Yes. We're currently tracking 12 recruiting vascular diseases studies with a site in Michigan, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a vascular diseases study in Michigan?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Michigan to take part?
- Not necessarily. These studies have a site in Michigan, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a vascular diseases trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New vascular diseases studies open in Michigan regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.